GSK Gsk Plc

TIDMGSK

RNS Number : 3232F

GlaxoSmithKline PLC

19 February 2018

GlaxoSmithKline plc (the 'Company')

Transaction notification

 
 1.   Details of PDMR/person closely associated 
       with them ('PCA') 
===  ========================================================== 
 a)   Name                   Mr N Hirons 
===  ======================  ================================== 
 b)   Position/status        SVP, Global Ethics & Compliance 
===  ======================  ================================== 
 c)   Initial notification/  Initial notification 
       amendment 
===  ======================  ================================== 
 2.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
===  ========================================================== 
 a)   Name                   GlaxoSmithKline plc 
===  ======================  ================================== 
 b)   LEI                    5493000HZTVUYLO1D793 
===  ======================  ================================== 
 3.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transaction(s) 
       has been conducted 
===  ========================================================== 
 a)   Description             GlaxoSmithKline plc American 
       of the financial        Depositary Shares ('ADSs') 
       instrument              ISIN: US37733W1053 
===  ======================  ================================== 
 b)   Nature of              The lapse of options over 4,600 
       the transaction        ADSs, granted on 19 February 
                              2008 under the GlaxoSmithKline 
                              Share Option Plan, at an option 
                              price of $44.75. 
===  ======================  ================================== 
 c)   Price(s) and             Price(s)   Volume(s) 
       volume(s)               ---------  --------------------- 
                                n/a        2,366 (Incentive 
                                            Stock Option) 
                               ---------  --------------------- 
                                n/a        2,234 (Non-Qualified 
                                            Stock Option) 
                               ---------  --------------------- 
===  ======================  ================================== 
 d)   Aggregated 
       information 
 
       Aggregated 
       volume Price           4,600 
                              n/a 
===  ======================  ================================== 
 e)   Date of the            2018-02-19 
       transaction 
===  ======================  ================================== 
 f)   Place of the           n/a 
       transaction 
===  ======================  ================================== 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHVKLFFVLFFBBB

(END) Dow Jones Newswires

February 19, 2018 13:12 ET (18:12 GMT)

Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024

Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024